Spexib Ceritininib Hard Gelatin Capsule 150mg Specific Drug
Accepts only Domestic inquiries
MRP: 5000.00 INR / PackWeight: 500.00 Gram1 Pack Contains 1Minimum Pack Size 1
In Stock
| Drug Type | Specific Drug |
| Ingredients | Spexib Ceritininib |
| Physical Form | Capsules |
| Function | Anti-Cancer |
| Recommended For | Indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test450 mg orally once daily with foodContinue until disease progression or unacceptable toxicityAlso, see the administrationDosage ModificationsDose reduction incrementsStarting dose: 450 mg once dailyFirst dose reduction: 300 mg once dailySecond dose reduction: 150 mg once dailyUnable to tolerate 150 mg/day: DiscontinueCoadministration with strong CYP3A4 inhibitorsAvoid concurrent use of strong CYP3A inhibitors during treatmentIf coadministration with a strong CYP3A inhibitor is unavoidable, reduce the dose by approximately one-third, rounded to the nearest multiple of the 150 mg dosage strengthAfter discontinuation of a strong CYP3A inhibitor, resume the dose that was taken before initiating the strong CYP3A4 inhibitor |
BUY NOW
Product Overview
Key Features
Spexib Capsule is used in the treatment of non-small cell lung cancer. It shows its working by stopping or slowing down the growth of cancer cells.
Indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test
450 mg orally once daily with food
Continue until disease progression or unacceptable toxicity
Also, see the administration
Dosage Modifications
Dose reduction increments
Starting dose: 450 mg once daily
First dose reduction: 300 mg once daily
Second dose reduction: 150 mg once daily
Unable to tolerate 150 mg/day: Discontinue
Coadministration with strong CYP3A4 inhibitors
Avoid concurrent use of strong CYP3A inhibitors during treatment
If coadministration with a strong CYP3A inhibitor is unavoidable, reduce the dose by approximately one-third, rounded to the nearest multiple of the 150 mg dosage strength
After discontinuation of a strong CYP3A inhibitor, resume the dose that was taken before initiating the strong CYP3A4 inhibitor
Indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test
450 mg orally once daily with food
Continue until disease progression or unacceptable toxicity
Also, see the administration
Dosage Modifications
Dose reduction increments
Starting dose: 450 mg once daily
First dose reduction: 300 mg once daily
Second dose reduction: 150 mg once daily
Unable to tolerate 150 mg/day: Discontinue
Coadministration with strong CYP3A4 inhibitors
Avoid concurrent use of strong CYP3A inhibitors during treatment
If coadministration with a strong CYP3A inhibitor is unavoidable, reduce the dose by approximately one-third, rounded to the nearest multiple of the 150 mg dosage strength
After discontinuation of a strong CYP3A inhibitor, resume the dose that was taken before initiating the strong CYP3A4 inhibitor
Product Specifications
| Drug Type | Specific Drug |
| Ingredients | Spexib Ceritininib |
| Physical Form | Capsules |
| Function | Anti-Cancer |
| Recommended For | Indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test450 mg orally once daily with foodContinue until disease progression or unacceptable toxicityAlso, see the administrationDosage ModificationsDose reduction incrementsStarting dose: 450 mg once dailyFirst dose reduction: 300 mg once dailySecond dose reduction: 150 mg once dailyUnable to tolerate 150 mg/day: DiscontinueCoadministration with strong CYP3A4 inhibitorsAvoid concurrent use of strong CYP3A inhibitors during treatmentIf coadministration with a strong CYP3A inhibitor is unavoidable, reduce the dose by approximately one-third, rounded to the nearest multiple of the 150 mg dosage strengthAfter discontinuation of a strong CYP3A inhibitor, resume the dose that was taken before initiating the strong CYP3A4 inhibitor |
| Dosage | 450mg |
| Suitable For | Suitable For All |
| Storage Instructions | Below 25 Degree Celsius |
| Payment Terms | Cash Against Delivery (CAD), Cash on Delivery (COD), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union, Paypal, Delivery Point (DP), Cash Advance (CA), Others, Days after Acceptance (DA), Cash in Advance (CID), Cheque |
| Supply Ability | 100 Per Day |
| Delivery Time | 2 Days |
| Sample Policy | Contact us for information regarding our sample policy |
| Packaging Details | Carton Box |
| Main Export Market(s) | Western Europe, Australia, North America, South America, Eastern Europe, Middle East, Africa, Central America, Asia |
| Main Domestic Market | All India |
| Shipping Rate | 5.00 |
| Unit Type | Pack/Packs |
| Moq | 1 |
| Pkg Box Length | 4.00 in |
| Currency | INR |
| Shipping Type | order_percent |
| GSTIN | 12% |
| Weight | 500.00 Gram |
| Price Type | fixed |
| Product Unit | 1 Pack/Packs |
| Packsize | 1 |
| MRP | 5000.00 INR |
| Brand Name | Spexib Ceritininib Hard Gelatin Capsule 150mg by MEDESY |
| Min Quantity | 1 |
| Stock Quantity | 500 |
| Pkg Box Height | 5.00 in |
| Pkg Box Breadth | 3.00 in |
| Max Quantity | 500 |
| Price | 4200.00 INR (Approx.) |
| Returnable | No |
| Mop | 1 |
| Minimum Order Quantity | 1 |
| Minimum Ordered Packs | 1 |
Explore in hindi - स्पेक्सिब सेरिटिनिब हार्ड जेलाटिन कैप्सूल 150 मिलीग्राम
Company Details
Business Type
Distributor, Supplier, Trading Company
Employee Count
9
Establishment
2020
Working Days
Monday To Saturday
GST NO
19AAWFG1734B1ZC
Payment Mode
Online Payments (NEFT/RTGS/IMPS)
Seller Details
M/s. GROWWFAST
GST
19AAWFG1734B1ZC
Partner
Mr Ajoy Singh
Member Since
3 Years
Address
1/3, Bangur Avenue, Ground Floor, Block- D, Kolkata, West Bengal, 700055, India
hard capsule gelatin in KolkataReport incorrect details
Related Products
More Products From This Seller
Explore Related Categories
- Tradeindia
- Empty Capsules
- Hard Capsule Gelatin
- Spexib Ceritininib Hard Gelatin Capsule 150mg In Bangur
Popular Products
Human HairForklift TrucksServo Voltage StabilizerBasmati RiceBackhoe LoaderCarry Bag Making MachineDrum LifterElectric StackerScissor LiftsIndustrial Vibrating ScreenRotameterFlowmeterRotary Air CompressorIndustrial Eto SterilizerRice Packaging MachinesShredding MachineHammer MillAutomatic Labelling MachineDiesel ForkliftAerial Work PlatformStorage Rack SystemEpoxy ResinMild Steel BarStainless Steel SheetsStainless Steel StripsBag Filling MachinesAsphalt PlantsSlat ConveyorOintment PlantPlanetary MixersLadies KurtisLed LightsCctv CameraBall ValveAnti Cancer MedicineAir CompressorIncense SticksSolar LightsGoods LiftsVitrified TilesStainless Steel CoilsPvc PipesPvc Pipe FittingsUpvc PipesUpvc Ball ValvePipe Elbows